|
|
MEETING PROGRAM
Sunday, August 23rd
08.00: Registration –Information open
08.30: Welcome coffee for Young Scientists
09.00-12.30: Young Scientists Meeting (room 3)
09.00-11.30: TIAFT Board meeting (room 14)
11.30-12.30: Regional representatives meeting (room 4)
12.30-14.00: Lunch for Young Scientists, TIAFT Board and Regional representatives
14.00-16.30: Workshop I – LC-MS/MS; GC-MS/MS SGMS / ccCTA (room 2)
14.00-16.30: Workshop II – Illicit Drug Profiling ESC (room 3)
14.00-16.30: Workshop III – Drugs and Driving DRUID (room 4)
17.00-19.00: Opening Ceremony (room 2)
19.00-20.30: Welcome reception sponsored by Agilent Technologies (1 st floor)
Monday, August 24th
08.00: Registration –Information open
08.45-19.00: Exhibition & Posters (Hall)
08.45-10.00: Session Postmortem Toxicology I (room 2)
08.45-10.00: Session New Trends in Analysis of Drugs I (room 3-4)
10.00-11.00: Coffee break sponsored by Roche Diagnostics
11.00-12.00: Session Postmortem Toxicology I (room 2)
11.00-12.00: Session New Trends in Analysis of Drugs I (room 3-4)
12.00-14.00: Lunch (1 st floor)
12.00-13.00: Poster session 1 (Hall)
13.00-14.00: Vendor seminar by Thermo Fisher Scientific GmbH (room 3-4)
14.00-15.15: Session Alcohol, Drugs and Driving (room 2)
14.00-15.15: Session New Trends in Analysis of Drugs II (room 3-4)
15.15-16.15: Coffee breaksponsored by Roche Diagnostics
16.15-17.15: Session Alcohol, Drugs and Driving (room 2)
16.15-17.15: Session New Trends in Analysis of Drugs II (room 3-4)
18.00-19.30: Vendor seminar by Agilent Technologies (room 3-4)
Tuesday, August 25th
08.00: Registration –Information open
08.45-12.00: Exhibition & posters (Hall)
08.45-10.00: Session Drugs of Abuse (room 2)
08.45-10.00: Session Postmortem Toxicology II (room 3-4)
10.00-11.00: Coffee break
11.00-12.00: Session Drugs of Abuse (room 2)
11.00-12.00: Session Postmortem Toxicology II (room 3-4)
12.00-19.00: Local excursion to Gruyères and Lausanne
19.00-22.30: Dinner Cruise on the Lake of Geneva
Wednesday, August 26th
08.00: Registration –Information open
08.45-19.00: Exhibition& Posters (Hall)
08.45-10.00: Session Doping Analysis I (room 2)
10.00-11.00: Coffee break sponsored by BGB Analytik AG
11.00-12.00: Session Doping Analysis I (room 2)
12.00-14.00: Lunch (1 st floor)
12.00-13.00: Poster session 2 (Hall)
13.00-14.00: Vendor seminar by Waters (room 3-4)
13.00-14.00: Vendor seminar by Roche (room 2)
14.00-15.15: Session Alternative Matrices in Forensic, Clinical and Food Toxicology I (room 2)
14.00-15.15: Session Doping Analysis II (room 3-4)
15.15-16.15: Coffee break sponsored by BGB Analytik AG
16.15-17.15: Session Alternative Matrices in Forensic, Clinical and Food Toxicology I (room 2)
16.15-17.15: Session Doping Analysis II (room 3-4)
19.30: Geneva Gala dinner at the Pittoef Theatre sponsored by Siemens
Thursday, August 27th
08.00: Registration –Information open
08.30-18.00: Exhibition& Posters (Hall)
08.30-09.45: Session Clinical Toxicology and Therapeutic Drug Monitoring (room 2)
08.30-09.45: Session Alternative Matrices in Forensic, Clinical and Food Toxicology II (room 3-4)
09.45-10.15: Coffee break
10.15-11.15: Session Clinical Toxicology and Therapeutic Drug Monitoring (room 2)
10.15-11.15: Session Alternative Matrices in Forensic, Clinical and Food Toxicology II (room 3-4)
11.15-12.15: Vendor seminar by Applied Biosystems Europe BV (room 3-4)
11.45-13.15: Lunch (1 st floor)
13.15-14.30: Session Chemometry and Method Validation (room 2)
13.15-14.30: Session Free Topics (room 3-4)
14.30-15.00: Coffee break
15.00-16.00: Session Chemometry and Method Validation (room 2)
15.00-16.00: Session Free Topics (room 3-4)
16.00-16.30: Closing Ceremony (room 2)
SCIENTIFIC PROGRAM
Sunday, August 23, 2009
| ROOM #3 |
|
|
| Welcome coffee for Young Scientists |
08:30 |
|
| Young Scientists Meeting |
09:00 |
|
| ROOM #14 |
|
|
| TIAFT Board meeting |
09:00 |
|
| ROOM #4 |
|
|
| Regional Representatives Meeting |
11:30 |
|
| Lunch for Young Scientists, Regional Representatives and TIAFT Board |
12:00 |
|
| ROOM #2 |
|
|
| Workshop I - LC-MS/MS; GC-MS/MS |
14:00 |
SGMS - ccCTA |
| ROOM #3 |
|
|
| Workshop II - Illicit Drug Profiling |
14:00 |
ESC |
| ROOM #4 |
|
|
| Workshop III - Drugs and Driving |
13:45 |
DRUID |
| ROOM #2 |
|
|
| Opening Ceremony |
17:00 |
|
| Chair: Marc Augsburger and Christian Staub |
|
|
| L01 – Intoxications with plants and methodologies for the safety assessment of herbal medicines K. Hostettmann |
17:30 |
|
| L02 – Genomic Medicine: Impact on Drug Efficacy and Toxicity U.A. Meyer |
18:15 |
|
| 1 st floor |
|
|
| Welcome reception |
19:00 |
Sponsored by Agilent Technologies |
TOP
Monday, August 24, 2009
| ROOM #2 |
|
ROOM #3-4 |
| |
|
New Trends in Analysis of Drugs, Metabolites and Natural Products I |
Chair: Robert Wennig and Patrice Mangin |
|
Chair: Giampietro Frison and Jean-Luc Veuthey |
L03 . Best practice post-mortem forensic toxicology O.H. Drummer |
08:45 |
O17. Analysis of Benzodiazepines in Blood and Urine with Automated Disposable Pipette Extraction and HPLC/MS/MS W.E. Brewer , F. D. Foster, T.Gluodenis |
| 09:00 |
O18. Rapid Quantification of Tilidine, Nortilidine and Naloxone in Urine by LC-ESI-MS/MS
C. Köhler , T. Grobosch, T. Binscheck |
O01 . Application of quantitative structure-activity relationships (QSARs) for modeling postmortem redistribution of structurally diverse drugs C. Giaginis , A. Tsantili-Kakoulidou, S. Theocharis |
09:15 |
O19. Capillary liquid chromatography with nano-electrospray ionization tandem mass spectrometry for ultra-sensitive analysis of drugs in hair M.C. Parkin , S.C. Turfus, D.A. Cowan, R.A. Braithwaite, A.T. Kicman |
O02 . Drug interaction research on a post-mortem database T. Launiainen , E. Vuori, I. Ojanperä |
09:30 |
O20. Detection and Identification of 700 Drugs by Multi Target Screening (MTS) with a QTrap 3200 LC-MS/MS and Library Searching S. Dresen, N. Ferreirós Bouzas, H. Gnann, W. Weinmann |
O03 . Investigation of chronic cocaine consumption from post-mortem hair analysis R.E. Cordero , S. Paterson |
09:45 |
O21. Construction of calibration locking databases for rapid and reliable drug screening by gas chromatography-mass spectrometry K. Kudo , W. Hikiji, M. Hayashida, K. Uekusa, N. Ikeda |
| Coffee break |
10:00 |
Sponsored by Roche Diagnostics |
Chair: Helena Teixeira and Robert Kronstrand |
|
Chair: Nerea Ferreirós and Jean-Luc Wolfender |
O04. Methadone concentration in liver and post-mortem blood D. Kappatos , M. Sage |
11:00 |
L04. Application of High Resolution LC/MS For The Analysis of Pharmaceutical Compounds, Biological Fluids and Natural Products R.S. Plumb , J.K. Nicholson |
O05. Problems of interpretation of post-mortem toxicological findings in babies and young children: a report of two cases H. Wollersen , F. Erdmann, R. Dettmeyer |
11:15 |
O06. Fast targeted screening of drugs and poisons in postmortem blood J. Beyer, J.L. Woods, N. George, D. Gerostamou-los, O.H. Drummer |
11:30 |
O22. Use of the biochip array technology in forensic toxicology - Comparison with Microplate EIA, GC-MS and LC-MS K.Y. Rust , S. Kunz, D. Bregel, J. Wilske, T. Kraemer |
O07. Strychnine: old poison, new deaths D. Gerostamoulos , J. Beyer, V. Staikos, S. Parsons, M. Lynch, O.H. Drummer |
11:45 |
O23. Evolution of liquid chromatography: current and future trends D. Guillarme , S. Rudaz, J.L. Wolfender, J.L. Veuthey |
| Lunch |
12:00 |
|
| |
|
|
Poster session I – poster P001 to P100 |
12:00 |
|
| |
|
ROOM #3-4 |
| |
13:00 |
Vendor seminar by Thermo Fisher Scientific GmbH |
ROOM #2 |
|
ROOM #3-4 |
Alcohol, Drugs and Driving |
|
New Trends in Analysis of Drugs, Metabolites and Natural Products II |
Chair: Alain Verstraete and Marc Augsburger |
|
Chair: Heesun Chung and Thomas Kraemer |
L05 . Alcohol, drugs and driving: situation and update in Sweden A.W. Jones |
14:00 |
O24 . Drug screening in whole blood with ultra performance liquid chromatography tandem mass spectrometry E.L. Øiestad , Å.M.L. Øiestad, U. Johansen, A.S. Christophersen |
| 14:15 |
O25 . Ketamine and norketamine detection in hair by Molecularly Imprinted Solid Phase Extraction versus Solid Phase Extraction prior to LC-/MS/MS N. Harun , E.I. Miller, R.A. Anderson, P.A. Cormack |
O33 . The prevalence of drugs amongst drivers of motor vehicles in Shanghai X. Zhuo , Y. Cang, J. Bu, B. Shen |
14:30 |
O26 . MRM3 – a Sophisticated Tool for Sensitive and Selective Detection of THC Carboxylic Acid directly from Hair J. Trafkowski , D. Thieme, H. Sachs, B. Schlutt, A. Besa |
O34. First nationwide study on driving under the influence of drugs in Switzerland M.C. Senna , M. Augsburger, B. Aebi, T. Briellmann, N. Donzé, J.L. Dubugnon, P.X. Iten, C. Staub, W. Sturm, K. Sutter |
14:45 |
O27 . Towards genuine identification without reference standards: application of fragmentation prediction in designer drug analysis A. Pelander , E. Tyrkkö, I. Rasanen, I. Ojanperä |
O35. Mortality and causes of death among drugged drivers P. Lillsunde , K. Karjalainen, T. Lintonen, A. Impinen, P. Mäkalä, O. Rahkonen, A. Ostamo |
15:00 |
O28 . Simultaneous Screening for and Determination of 128 Date-Rape Drugs in urine by GC-EI-MS P. Adamowicz , M. Kala |
| Coffee break |
15:15 |
Sponsored by Roche Diagnostics |
Chair: Cornelia Brehmer and Aldo Polettini |
|
Chair: Osamu Suzuki and Frank Musshof |
O36 . Quality Assurance in road traffic analyses in Switzerland T. Briellmann , T. Sigrist, M. Augsburger, B. Favrat, A. Oestreich, A. Deom |
16:15 |
O29 . Comparison of rapid LC-MS/MS screening with conventional GC-MS screening in forensic toxicology O.H. Drummer , J. Beyer, D. Gerostamoulos |
O37 . Statistical modelling of measurement errors in gas chromatographic analyses of blood alcohol content R. Moroni , J. Corander, P. Blomstedt, T. Reinikainen, E. Sippola |
16:30 |
O30 . Drug hair analysis by liquid chromatography–high resolution mass spectrometry in an Orbitrap D. Favretto , G. Frison, S. Vogliardi, G. Stocchero, F. Zancanaro, A. Nalesso, S.D. Ferrara |
O38 . Selective detection of phosphatidyl-ethanol homologues in blood as biomarkers for alcohol misuse by LC-ESI-MS/MS H. Gnamm , W. Weinmann, C. Engelmann, A. Thierauf, F. Wurst, G. Skopp, M. Winkler, S. Dresen, N. Ferreiros Bouzas |
16:45 |
O31 . Development of mass spectrometric method for identifying novel enzymes targeted by anti-cholinesterase organophosphorus compounds using shotgun proteome strategies K. Tsuge , M. Kanamori-Kataoka, I. Ohsawa, S. Kishi, T. Ohmori, Y. Seto, H. Fukushima |
O39 . Analysis of phosphatidylethanol in blood by non-aqueous capillary electrophoresis with on-line ESI-MS detection A. Nalesso , G. Viel, G. Cecchetto, M. Montisci, G. Frison, D. Favretto, S.D. Ferrara |
17:00 |
O32 . Radiological detection of dissolved cocaine S. Grabherr , G. Gambarota, A. Leimgruber, R. Meuli, P. Mangin, M. Augsburger |
| |
|
ROOM #3-4 |
| |
18:00 |
Vendor seminar by Agilent Technologies |
TOP
Tuesday, August 25, 2009
| |
|
|
| Drugs of Abuse |
|
Postmortem Toxicology II |
Chair: Marilyn Huestis and Nicolas Donzé |
|
Chair: Sue Paterson and Thomas Briellmann |
L06 . Neurobiology of addiction L.P. Raymon |
08:45 |
O08 . Metals distribution in tissues of deceased individuals J.-P. Goullé , L. Mahieu, J. G. Anagnostides, A. Roumajon, E. Saussereau, M. Guerbet, C. Lacroix |
| 09:00 |
O09 . Platinum in internal organs and blood after cisplatin overdose J. K. Sadlik |
O40 . Formation of oxidation products of (-)-trans-Δ 9-tetrahydrocannabinol-9-carboxylic acid (THC-COOH) after exposure to oxidizing adulterants N. Charlton , J. Lewis, M. Dawson, S. Fu |
09:15 |
O10 . Post mortem blood and vitreous Ethyl Glucuronide and Ethyl Sulphate E. Jenkins , J.H. Galloway, S. Morley |
O41 . Interest of qualitative and quantitative profiling of endocannabinoids for evaluation of their implication in drug addiction process A. Thomas , C. Giroud, E. Fornari, G. Hopfgartner, C. Staub |
09:30 |
O11 . Potassium chloride and gamma-hydroxybutyrate distribution: about an unusual case A.L. Pelissier-Alicot , P. Kintz, V. Coste, J. Desfeux, G. Leonetti |
O42 . Quantitative Determination of the Active ’Spice’ Ingredient JWH- 018 in Blood and Hair by Liquid Chromatography - Tandem Mass Spectrometry M.A. Neukamm , T.E. Mürdter, H.-D. Wehner, F. Wehner, M. Renge, D. Ratge, H. Sachs, C. Knabbe |
09:45 |
O12 . Determination of ethylene glycol, glycolic acid and formic acid in blood and urine by in-tube extraction and gas chromatography – mass spectrometry J. Viinamäki, I. Rasanen, E. Vuori, I. Ojanperä |
| Coffee break |
10:00 |
Coffee break |
Chair: Lionel Raymon and Frank Sporkert |
|
Chair: Ilkka Ojanperä and Werner Bernhard |
O43 . Studies on the metabolism of JWH-018 and of a homologue of CP 47,497, pharmacologically active ingredients of different misused incense (“Spice”) using GC-MS and LC-MSn techniques T. Kraemer , K.Y. Rust, M.R. Meyer, D.K. Wisse-nbach, D. Bregel, M. Hopf, H.H. Maurer, J. Wilske |
11:00 |
O13 . Establishment of a simple and rapid determination method for a small amount of propofol in biological samples by gas chromatography-mass spectrometry W. Hikiji , K. Kudo |
O44 . Cannabis intoxication with perceptual disturbances under clinical setting C. Giroud, A. Thomas, J.-F. Mall, B. Favrat, M. Appenzeller, T. Buclin, E. Fornari, G. Battistella, P. Maeder, C. Staub, J.-M. Annoni, P. Mangin |
11:15 |
O14 . Analysis of hair after contamination with blood containing cocaine and blood containing benzoylecgonine S. Paterson , S. Lee, R. Cordero |
O45 . Metabolism of the New Designer Drug Mephedrone and Toxicological Detection of the Beta Keto Designer Drugs Mephedrone, Butylone and Methylone in Urine M.R. Meyer , F.T. Peters, H.H. Maurer |
11:30 |
O15 . The Role of Oxycodone Metabolites in Oxycodone Related Fatalities in the West of Scotland A.I. Al-Asmari , R.A. Anderson, G. Cooper |
O46 . Studies on the metabolism of the Kratom alkaloid paynantheine in rat and human urine using liquid chromatography-linear ion trap mass spectrometry A.A. Philipp , D.K. Wissenbach, A.A. Weber, S.W. Zoerntlein, J. Kanogsunthornrat, H.H. Maurer |
11:45 |
O16 . Confession of a murder – Acquittal by a hair’s breadth K.Y. Rust, C. Schyma, M. Hopf, S. Warth, D. Bregel, J. Wilske, T. Kraemer |
Excursion |
|
|
| Lunch – excursion to Gruyères and Lausanne |
12:00 |
|
| Dinner Cruise on the Lake of Geneva |
19:30 |
|
TOP
Wednesday, August 26, 2009
|
|
ROOM #3-4 |
| Doping Analysis I |
|
|
Chair: Olaf Drummer and Martial Saugy |
|
L07. Past Present and Future of Anti-doping Analyses D.H. Catlin |
09:00 |
L08. The Athlete’s Biological Passport P.-E. Sottas |
09:30 |
| Coffee break |
10:00 |
Sponsored by BGB Analytik AG |
L09. Doping control analysis of peptides and proteins using LC-MS/MS M. Thevis |
11:00 |
|
L10. Cannabis Testing in Sport M. Huestis |
11:30 |
| Lunch |
12:00 |
Hall |
|
|
Poster session II – poster P100 to P171 and last minute poster |
12:00 |
|
|
|
ROOM #3-4 |
| Vendor seminar by Roche Diagnostics and OraSure Technologies |
13:00 |
Vendor seminar by Waters |
|
|
ROOM #3-4 |
| Alternative Matrices in Forensic, Clinical and Food Toxicology II |
|
Doping Analysis II |
Chair: Pierre Margot and Christian Staub |
|
Chair: Mario Thevis and Christophe Saudan |
L11. Alternatives matrices (oral fluid, hair) in forensic toxicology and doping control: revolution with political issues or other specimens with financial issues? P. Kintz |
14:00 |
O47. Analysis of sulfate conjugates improves detection of some anabolic steroids in urine V. Uralets |
| 14:15 |
O48. Determination of testosterone misuse in sport, an international comparative study E. Strahm, P.-E. Sottas, J. Dvorak, M. Saugy, C. Saudan |
O52. Ethyl glucuronide in hair: sensitivity, specificity, and factors potentially influencing its performance L. Politi , L. Mor ini, A. Polettini |
14:30 |
O49. Doping Control Analysis of Recombinant Human Erythropoietin and Darbepoetin Alfa in Equine Plasma by Nano Liquid Chromatography-Tandem Mass Spectrometry N.H. Yu , E.N.M. Ho, T.S.M. Wan, A.S.Y. Wong |
O53. Hair analysis for anabolic steroids: the time courses in guinea pigs M. Shen , P. Xiang, B. Shen, J. Bu, H. Yan |
14:45 |
O50. Fast screening and confirmation of doping agents by UHPLC-QTOF-MS/MS F. Badoud , E. Grata, L. Perrenoud, M. Saugy, S. Rudaz, J.-L. Veuthey |
O54. Hair analysis for the most common drugs of abuse in young children V. Staikos , J. Beyer, D. Gerostamoulos, O.H. Drummer |
15:00 |
O51. Smoked Cannabis and Doping Control: Looking for the Wrong Target Analyte ? R. Brenneisen , P. Meyer, H. Chtioui, M. Saugy, C. Schweizer, M. Kamber |
| Coffee break |
15:15 |
Sponsored by BGB Analytik AG |
Chair: Christèle Widmer and Pascal Kintz |
|
|
O55. Qualitative identification of ten benzodiazepines and ketamine in hair samples with application to drug-facilitated sexual assault investigations M. Montgomery , M. LeBeau |
16:15 |
O56. Interpretation of GHB concentrations in hair. Application in drug-facilited crime and abuse cases V. Cirimele , E. Vallet, M. Villain, P. Kintz |
16:30 |
O57. Use of Rivotril® in Drug-Facilitated Sexual Assault: victim and/or user? F. Aknouche , T. Besnard, V. Maignant, R. Buti, H.-P. Duval |
16:45 |
O58. Validation of a MALDI-based screening method for the detection of cocaine in hair S. Vogliardi , D. Favretto, G. Frison, S. Maietti, G. Viel, R. Seraglia, P. Traldi, S.D. Ferrara |
17:00 |
Pittoef Theatre |
|
|
| Gala dinner |
19:30 |
Sponsored by Siemens |
TOP
Thursday, August 27, 2009
|
|
ROOM #3-4 |
| Clinical Toxicology and Therapeutic Drug Monitoring |
|
Alternative Matrices in Forensic, Clinical and fFood Toxicology II |
Chair: Katharina Rentsch and Hans H. Maurer |
|
Chair: Marc Deveaux and Patrick Edder |
L12. Clinical Chemistry and Toxicology D. Hochstrasser |
08:30 |
O59. Liquid chromatography-ion trap-mass spectrometry assay for the simultaneous determination of methadone, cocaine, opiates and metabolites in human umbilical cord A. de Castro , M. Concheiro, D.M. Shakleya, M.A. Huestis |
| 08:45 |
O60. Concentration Profiles of Methylphenidate in Serum and Oral Fluid of Children Under Medical Treatment with an Extended-Release Preparation J. Kempf, R. Kuhn, C. Fleischhaker, K. Schneider-Momm, W. Weinmann |
O67. Fast and Simple Liquid-Liquid Extraction Method for LC-MS/MS Quantification of 140 Analytes from Different Drug Classes in Human Plasma D. Remane , M.R. Meyer, F.T. Peters, H.H. Maurer |
09:00 |
O61. Screening of 17 benzodiazepines in artificial lachrymal fluids using Liquid Chromatography coupled to Tandem Mass Spectrometry T. Besnard , F. Aknouche, H.P. Duval , J. Chofflet |
O68. General Unknown Screening of illicit drugs: a novel approach using high resolution and accurate mass B. Duretz , E. Génin, S. Scurati, S. Robinson |
09:15 |
O62. On-line desorption of dried blood spot: a novel approach for the direct LC/MS analysis of µ-whole blood samples J. Déglon , A. Thomas, C. Staub |
O69. Development and validation of a drugs screening method in biological matrices using an hybrid LC-MS/MS system V. Viette , M. Fathi, D. Hochstrasser, R. Mylonas, Y. Mauron, S. Rudaz, J.-L. Veuthey |
09:30 |
O63. The detection and quantification of lorazepam and its phase II metabolite in fingerprint deposits by LC-MS/MS E. Goucher , A. Kicman, N. Smith, S. Jickells |
| Coffee break |
09:45 |
|
Chair: Jean-Pierre Goullé and Marc Fathi |
|
Chair: Marc A. LeBeau and Hans Sachs |
O70. Therapeutic Drug Monitoring of 14 Antiretroviral Drugs using LC-MS U. Gutteck-Amsler, K.M. Rentsch |
10:15 |
O64 . Prenatal tobacco exposure, meconium nicotine biomarkers and infant outcomes T.R. Gray, R.D. Eiden, M.A. Huestis |
O71. Workup of Urine Samples for Systematic Toxicological Analysis Using GC-MS: Acid hydrolysis/Liquid-liquid Extraction/Acetylation versus Miniaturized Enzymatic Hydrolysis/Liquid-liquid Extraction/Acetylation C. Sauer , K. Hoffmann, L. Messerschmidt, M.R. Meyer, H.H. Maurer, F.T. Peters |
10:30 |
O65. Munchausen syndrome by proxy. A special forensic toxicological analysis challenge M. Deveaux , J. Schwarz, M. Chèze, G. Hoizey, G. Pépin |
O72. Normetabolites of hydrocodone, oxycodone and codeine are useful biological markers for interpretation of drug source in pain patients E.J. Cone , Y.H. Caplan, A. Zichterman, T. Robert, R.M. Heltsley, B.S. Cawthon, D.L. Black |
10:45 |
O66. The minimal dosage of ketamine and triazolam detectable in hair after administration P. Xiang , M. Shen, Q. Sun |
O73. Acute propylene glycol ingestion treated with fomepizole and haemodialysis B. Brunet , O. Longuet, M. Labadie, P. Mura |
11:00 |
|
| |
|
|
| |
11:15 |
Vendor seminar by Applied Biosystems Europe BV |
| Lunch |
11:45 |
|
ROOM #2 |
|
ROOM #3-4 |
Chemometry and Method Validation |
|
Free Topics |
Chair: Corinne Charlier and Serge Rudaz |
|
Chair: Daniel Isenschmid and Olivier Plaut |
L13. The necessity and interest of Chemometrics D. Rutledge |
13:15 |
|
| |
|
O74. Comparison of Bias/Precision- and beta-Expectation Interval-based Accuracy Evaluation for Six-point and One-Point Calibration – A Retrospective Analysis of Six Validated Assays F.T. Peters |
13:45 |
O81. Dosis facit venenum? R.K. Mueller |
O75. Total Error for the validation of bioanalytical methods E. Rozet , B. Boulanger, S. Rudaz, R. Marini, E. Ziemons, P. Hubert |
14:00 |
O82. Determination of four pyrethroids pesticides in blood by solid-phase extraction and negative-ion chemical ionization gas chromatography/tandem mass spectrometry Y. Wang |
O76. Use of accuracy profile for the validation of a gas chromatography-negative chemical ionization tandem mass spectrometry method: quantification of ethyl glucuronide in hair H. Kharbouche , F. Sporkert, M. Augsburger, P. Mangin, C. Staub |
14:15 |
O83. Impact of lead exposure on serum Paraoxonase 1 (PON1) activity and genotype in occupationally- exposed Egyptian workers S.S. Ghaleb , M. Elkhatib, M. Kamal, M. Fathy, M. Hasan |
| Coffee break |
14:30 |
|
Chair: Frank Peters and Pierre Esseiva |
|
|
O77. Screening for Pharmaco/Toxicologically Relevant Compounds in Biosamples using High Mass Resolution. A Metabolomic Approach E. Liotta, R. Gottardo, A. Bertaso, A. Polettini |
15:00 |
O84. Evaluation method for linking drug seizures using stable carbon and nitrogen isotopic compositions: A complementary study with impurity profiling Y.T. Iwata , H. Inoue, K. Kuwayama, K. Tsujikawa, H. Miyaguchi, T. Kanamori, H. Fukushima |
O78. Searching for biomarkers of disease through an untargeted metabonomic approach D. Favretto , G. Cecchetto, E. Cosmi, G. Stocchero, S. Vogliardi, G. Frison, C. Terranova, E. Ragazzi, S.D. Ferrara |
15:15 |
O85. Sample preparation in Systematic Toxicological Analysis T. Stimpfl |
O79. Characterization of illicit amphetamines through 13C/12C and 15N/14N isotopic ratio measurements A. Salomone , M. Franzoni, D. Caneparo, M. Vincenti |
15:30 |
O86. Monitoring of herbal mixtures potentially containing cannabinoid designer drugs as psychoactive adulterants N. Ferreirós , S. Dresen, M. Pütz, V. Auwärter |
O80. Transfer of heroin profiling method from conventional GC-MS to Fast-GC-MS & UHPLC-MS/MS B. Debrus , J. Broséus, D. Guillarme, P. Hubert, J.-L. Veuthey, P. Esseiva, S. Rudaz |
15:45 |
|
ROOM #2 |
|
|
| |
16:00 |
|
ROOM #2 |
|
|
TIAFT Business meeting |
16:30 |
|
TOP
| INVITED SPEAKERS |
Opening Ceremony
Prof. Kurt Hostettmann, Switzerland
Prof. Urs Meyer, Switzerland |
|
| |
|
| Oral sessions |
|
| Postmortem Toxicology: |
Prof. Olaf Drummer, Australia |
| Alcohol, Drugs and Driving: |
Prof. A. Wayne Jones, Sweden |
| Clinical Toxicology and Therapeutic Drug Monitoring: |
Prof. Denis Hochstrasser, Switzerland |
| Doping Analysis: |
Dr. Marilyn Huestis, USA
Prof. Don Catlin, USA
Prof. Mario Thevis, Germany
Dr. Pierre-Edouard Sottas, Switzerland |
| Drugs of Abuse: |
Dr. Lionel Raymon, USA |
| New Trends in Analysis of Drugs, Metabolites and Natural Products: |
Dr. Robert Plumb, United Kingdom |
| Chemometry and Data Treatment: |
Prof. Douglas Rutledge, France |
| Alternative Matrices in Forensic, Clinical and Food Toxicology: |
Dr. Pascal Kintz, France |
| Free Topics: |
- |
|
